Colposcopy Market Size, Share & Trends Analysis Report By Modality (Optical, Video), By Application (Pelvic, Oral), By Portability (Handheld, Stationary), By End-use, By Region, And Segment Forecasts, 2022 - 2030

Report Overview

The global colposcopy market size was valued at USD 427.0 million in 2021 and is anticipated to expand at a compound annual growth rate (CAGR) of 4.8% from 2022 to 2030. Factors such as the rise in the prevalence of cervical cancer and the high demand for early diagnostic techniques are expected to boost market growth. According to Global Cancer Observatory, in 2020, about 604,127 new cases of cervical cancer were diagnosed globally and 341,831 deaths occurred in the same year due to the disease. Additionally, by 2025, the incidence of cervical cancer is expected to increase to 1,495,211.

Colposcopy is a highly efficient technique for early diagnosis of lesions and selecting biopsy sites due to its high precision, adaptability, ease of use, and non-invasive approach. It further allows for a magnified evaluation of the cervix and lower genital tract for either dysplastic or malignant epithelial lesions. For decades, gynecological examinations were subjected to a time-consuming and inconvenient clinical experience including outmoded equipment and an uncomfortable visit. However, in recent years, there have been significant technological advancements in this field. Major market players have been adopting advanced technologies by integrating various digital platforms with colposcopy equipment. 

The integration is expected to introduce high-resolution imaging devices that are most likely to replace traditional colposcopes, hence influencing the market dynamics. Increasing awareness and adoption of preventive healthcare and disease screening programs is expected to propel the growth of the market. For instance, in April 2021, as part of China's efforts to protect women's health, more than 120 million cervical cancer screenings were conducted for free. Improved image quality is expected to improve diagnostic precision in the early stages of cervical cancer. This can help with a faster diagnosis and treatment. Thus, the growing usage of colposcopy for diagnosing various diseases is expected to contribute to market growth. 

The COVID-19 pandemic negatively impacted the market for colposcopy. A significant decline in cancer screening was witnessed across the globe. However, the market is expected to steadily grow by mid-2022. The WHO also aims at reducing 10% cases of cervical cancer by 2030, and preventing 70 million cases by 2120, by encouraging end-users to adopt high-end technologies for early detection of the disease. This is expected to significantly boost the market in the coming years. 

Modality Insights 

The optical colposcope segment dominated the market and held the largest revenue share of 69.3% in 2021. The optical colposcope is a traditional colposcope, made up of three parts: the head, which holds the optics; the light source; and the body, which can be portable or non-portable. The adoption of the optical colposcope is high in developing countries. High affordability and low maintenance are some of the key driving factors of this segment. 

The video colposcope segment is anticipated to witness the fastest growth during the forecast period. Video modality provides visual clarity and motion pictures that help in accurate diagnosis. Video colposcopes can autofocus the image if kept at a distance of 25–30 cm from the object. With video colposcopy, patients spend significantly less time in the exam room than in a conventional optical colposcopy-based exam. In addition, this system stores data, which can later be played or recalled on a screen. Thus, all these factors are expected to boost the growth of the segment during the forecast period. 

Application Insights 

The pelvic examination segment dominated the market and accounted for the largest revenue share of 88.6% in 2021. The segment is anticipated to continue its dominance over the forecast period. This is due to the increasing cases of gynecological disorders. When the result of a pap smear is abnormal, colposcopy helps in identifying the problem more clearly. Pelvic colposcopy examinations are used to analyze the inflammation, infection, cancerous changes, traumatic injuries in the vagina, and cervix. Due to its high negative predictive value, colposcopy is a useful cervical cancer screening method. 

The oral examination segment is expected to grow at a significant rate during the forecast period, owing to the increasing prevalence of premalignant lesions and oral cancers globally. The condition is fatal, and delayed treatment leads to a high rate of morbidity. According to the global cancer observatory, oral cavity cancer accounted for 177,757 deaths in 2020. However, oral cancer can be treated if diagnosed early. Studies suggest that colposcope is highly efficient in detecting oral lesions in comparison with other methods. 

Portability Insights 

The stationary colposcope segment dominated the market and held the largest revenue share of 64.0% in 2021. In developing countries, where the adoption of new technology is slower, stationary colposcopes are in high demand. The market is predicted to grow due to constant technological advancements such as high-quality digital images, improved magnification, and HD camera technology. This technology has added a new variable that can be utilized for efficient diagnosis. 

The handheld colposcope segment is estimated to register the fastest CAGR of 6.1% during the forecast period. The portability, ease of use, and compact nature of handheld colposcopes have increased their acceptance in smaller clinics. In addition, handheld colposcopy systems can be carried around the hospital as well as to a patient’s home. It permits gynecological examinations at any location, thereby increasing access for patients. The demand for handheld colposcopes is anticipated to increase, especially in point-of-care, home care, and emergency care settings, which will attract the attention of new market players. 

End-use Insights

The hospital segment accounted for the largest revenue share of 32.1% in 2021 and is expected to continue its dominance over the forecast period. Hospitals are well-equipped with necessary instruments used for the screening of the cervix for the detection of any precancerous and cancerous growth, thus leading to the large number of patients visiting hospitals. The rising acceptance rate for technologically advanced biopsy and the use of colposcopy for early diagnosis of cervical cancer are factors likely to drive segment growth. 

The diagnostic center segment is expected to witness significant growth during the forecast period. The growing patient population with cervical cancer, are providing an opportunity for clinicians to provide stand-alone outpatient diagnostic centers. Diagnostic centers also work to differentiate their service offerings, quality, and test accuracy by focusing on brand building through online marketing initiatives. Healthcare camps, advertising campaigns, and preventive and wellness test packages are all part of their campaigning. Thus, the aforementioned factors are contributing to segment growth. 

Regional Insights 

North America dominated the colposcopy market with the largest revenue share of 31.0% in 2021, owing to an increase in the prevalence of cervical cancer and a rise in healthcare expenditure. Factors such as the adoption of colposcopy equipment, easy access to healthcare technologies, and the presence of significant distribution channels are expected to boost the market growth. According to the Centers for Medicare and Medicaid Services, the U.S. government spent nearly USD 4.1 trillion on healthcare in 2020, accounting for approximately 19.7% of the total GDP.

In Asia Pacific, the market is estimated to witness the fastest CAGR during the forecast period owing to the presence of a large patient pool and the growing need for technologically advanced and cost-effective healthcare solutions. Furthermore, market expansion in this region is aided by an increase in the number of hospitalizations and significant developments in the clinical development framework of developing economies.

Key Companies & Market Share Insights

The key players are developing advanced colposcopes to meet the growing prevalence of cervical cancer. Moreover, regional and service portfolio expansions and mergers and acquisitions are key strategies adopted by these players. For instance, In July 2021, DYSIS Medical Inc. announced the launch of DYSIS View - a compact and portable colposcope that uses the company's cutting-edge computer-aided cervical mapping technology, aiding healthcare professionals in clearly detecting cervical abnormalities. Some of the prominent players in the colposcopy market include:

• Kaps GmbH & Co. KG

• Carl Zeiss Meditec AG

• CooperSurgical, Inc

• DYSIS Medical Inc

• ATMOS Medizin Technik GmbH & Co. KG

• Olympus Corporation

• McKesson Medical-Surgical Inc.

• Ecleris

• Optomic

• Seiler Instrument Inc. 

Colposcopy Market Report Scope

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For the purpose of this study, Grand View Research has segmented the global colposcopy market report on the basis of modality, application, portability, end-use, and region:

• Modality Outlook (Revenue, USD Million, 2018 - 2030)

  • Optical

  • Video

• Application Outlook (Revenue, USD Million, 2018 - 2030)

  • Pelvic

  • Oral

• Portability Outlook (Revenue, USD Million, 2018 - 2030)

  • Handheld

  • Stationary

• End-use Outlook (Revenue, USD Million, 2018 - 2030)

  • Hospitals

  • Diagnostic centres

  • Gynaecology clinic

  • Specialty clinics

  • Ambulatory surgical centre

  • Research and academics

• Regional Outlook (Revenue, USD Million, 2018 - 2030)

  • North America

    • U.S.

    • Canada

  • Europe

    • U.K.

    • Germany

    • France

    • Italy

    • Spain

  • Asia Pacific

    • Japan

    • China

    • India

    • South Korea

  • Latin America

    • Brazil

    • Mexico

    • Argentina

  • Middle East and Africa

    • South Africa

    • Saudi Arabia

    • UAE